‘Multi-omics’ is changing how India spots and treats TB, cancers
In the last decade, India’s use of genomics has undergone a significant transformation, so much so that the diagnoses, management, and treatment of many diseases — including tuberculosis, cancers, and those caused by antimicrobial resistance — stand on the cusp of a revolution. Most recently, in January 2024, the Department of Biotechnology said it had completed…
Read More “‘Multi-omics’ is changing how India spots and treats TB, cancers” »